Integration of polygenic risk scores with modifiable risk factors improves risk prediction: results from a pan-cancer analysis
暂无分享,去创建一个
J. Witte | E. Ziv | M. Johansson | R. E. Graff | K. Smith-Byrne | S. Rashkin | L. Kachuri | Travis J Meyers | R. Graff
[1] J. Witte,et al. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts , 2020, Nature Communications.
[2] Benjamin Neale,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .
[3] M. Inouye,et al. Towards clinical utility of polygenic risk scores. , 2019, Human molecular genetics.
[4] J. Danesh,et al. Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke , 2019, Nature Communications.
[5] M. Ikram,et al. Genetic predisposition, modifiable risk factor profile and long-term dementia risk in the general population , 2019, Nature Medicine.
[6] J. Witte,et al. Pan-Cancer Study Detects Novel Genetic Risk Variants and Shared Genetic Basis in Two Large Cohorts , 2019, bioRxiv.
[7] C. Friedenreich,et al. The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results. , 2019, Preventive medicine.
[8] C. Friedenreich,et al. The burden of cancer attributable to modifiable risk factors in Canada: Methods overview. , 2019, Preventive medicine.
[9] D. Duggan,et al. Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts , 2019, Cancer medicine.
[10] Matthew S. Lebo,et al. Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood , 2019, Cell.
[11] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[12] Mathieu Lemire,et al. Discovery of common and rare genetic risk variants for colorectal cancer , 2018, Nature Genetics.
[13] I. Tzoulaki,et al. The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study , 2018, British Journal of Cancer.
[14] M. Oudkerk,et al. PL02.05 Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial , 2018, Journal of Thoracic Oncology.
[15] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[16] S. Sharp,et al. Development and Validation of Lifestyle-Based Models to Predict Incidence of the Most Common Potentially Preventable Cancers , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[17] E. Topol,et al. The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.
[18] Stephanie E. Moser,et al. Exploring various polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative and the UK Biobank with a visual catalog: PRSWeb , 2018, bioRxiv.
[19] Mary E. Haas,et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.
[20] Stephanie E. Moser,et al. Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative , 2017, bioRxiv.
[21] Julian Wolfson,et al. Performance of the Net Reclassification Improvement for Nonnested Models and a Novel Percentile-Based Alternative , 2018, American journal of epidemiology.
[22] P. Pharoah,et al. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study , 2018, Journal of Medical Genetics.
[23] N. Malats,et al. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. , 2018, International journal of epidemiology.
[24] A. Gavin,et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 , 2018, British Journal of Cancer.
[25] Peter Kraft,et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.
[26] Thomas A. Gerds,et al. riskRegression: Predicting the Risk of an Event using Cox Regression Models , 2017, R J..
[27] C. Sudlow,et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population , 2017, American journal of epidemiology.
[28] S. Vansteelandt,et al. Doubly robust estimation of attributable fractions in survival analysis , 2017, Statistical methods in medical research.
[29] Martin Eklund,et al. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial , 2017, Journal of the National Cancer Institute.
[30] E. Boerwinkle,et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.
[31] A. Sjölander,et al. Model-based estimation of the attributable fraction for cross-sectional, case–control and cohort studies using the R package AF , 2016, European Journal of Epidemiology.
[32] T. Marteau,et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis , 2016, British Medical Journal.
[33] G. Parmigiani,et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.
[34] Witold Zatonski,et al. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. , 2015, Cancer epidemiology.
[35] Pui-Yan Kwok,et al. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. , 2015, Cancer discovery.
[36] 杜昕,et al. Systematic review with meta–analysis , 2015 .
[37] Olga V. Demler,et al. Tests of calibration and goodness‐of‐fit in the survival setting , 2015, Statistics in medicine.
[38] K. D. Sørensen,et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[39] M. Kattan,et al. Calibration plots for risk prediction models in the presence of competing risks , 2014, Statistics in medicine.
[40] B. Brunekreef,et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). , 2013, The Lancet. Oncology.
[41] Janet W. Dyk,et al. SUMMARY OF RESULTS , 1968, Virtual Pilgrimage.
[42] M. Pencina,et al. Understanding increments in model performance metrics , 2012, Lifetime Data Analysis.
[43] Nilanjan Chatterjee,et al. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. , 2013, Cancer research.
[44] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[45] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[46] M. Greene,et al. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study , 2006, Cancer.
[47] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[48] P. Heagerty,et al. Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.
[49] R. Wooster,et al. Breast and ovarian cancer. , 2003, The New England journal of medicine.
[50] J Benichou,et al. Estimates of absolute cause-specific risk in cohort studies. , 1990, Biometrics.
[51] 藤倉雄二,et al. わが国における成人市中肺炎原因微生物についてのsystematic review/meta‐analysis , 2016 .
[52] L. Döbrőssy,et al. [European Code against Cancer: 12 ways to reduce your cancer risk]. , 2016, Orvosi hetilap.
[53] R. Kurtz,et al. Epidemiology of pancreatic cancer and the role of family history , 2013, Journal of surgical oncology.